Signal-averaged ECG in patients with antidepressant therapy

Area of Science:

• Cardiology
• Psychopharmacology
• Medical Technology

Background:

• Signal-averaged electrocardiography (SAECG) is used to identify patients at risk of ventricular arrhythmias and sudden cardiac death.
• Tricyclic antidepressants share pharmacological similarities with class I antiarrhythmics, raising concerns about potential proarrhythmic effects.
• The influence of sodium channel blocking antidepressants on SAECG parameters requires further investigation.

Purpose of the Study:

• To evaluate the impact of sodium channel blocking antidepressant drugs on time-domain parameters of SAECG.
• To assess changes in SAECG variables before and after initiating antidepressant therapy in depressed patients.
• To explore the potential of SAECG in risk stratification of psychiatric patients undergoing antidepressant treatment.

Main Methods:

• Signal-averaged electrocardiography (SAECG) was performed on 11 depressed patients with normal cardiac status.
• SAECG measurements were taken before and after 4 weeks of antidepressant initiation.
• High-pass filters of 25 Hz and 40 Hz were utilized to analyze SAECG time-domain parameters.

Main Results:

• Antidepressant therapy significantly worsened SAECG parameters, including prolonged filtered QRS duration and reduced root mean square voltages.
• Both 25 Hz and 40 Hz high-pass filters revealed similar adverse effects on SAECG variables.
• Late potentials (LP) were induced by amitriptyline and maprotiline in 2 patients at a 40 Hz filter setting.

Conclusions:

• Sodium channel blocking antidepressants can significantly affect SAECG variables, mirroring effects seen with class I antiarrhythmics.
• SAECG may serve as a valuable tool for categorizing antidepressant agents and stratifying cardiac risk in psychiatric patients.
• This pilot study highlights the importance of monitoring cardiac electrophysiology during antidepressant therapy.